MK

Mukesh Kumar Pawan

Active Director Director DIN 08782254
DIN 08782254 First appointment Jul 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Kumar Pawan

Data last updated:

Mukesh Kumar Pawan is a Director at Drsaheb Clinic Private Limited (since 2020). The company operates in Healthcare.

DIN 08782254
Primary Designation Director
Industry Healthcare
First Appointment 05 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drsaheb Clinic Private Limited U85110BR2020PTC046645
Director05 Jul 20202020Active

Board colleagues of Mukesh Kumar Pawan

NameDINCompanyDesignation
Sarita09240845Drsaheb Clinic Private LimitedAdditional Director
Saumya Bhardwaj08782253Drsaheb Clinic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drsaheb Clinic Private Limited
Premium access

Shareholding and investment profile for Mukesh Kumar Pawan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Kumar Pawan

Mukesh Kumar Pawan currently holds 1 directorship: Drsaheb Clinic Private Limited (Director, since 05 Jul 2020).

Mukesh Kumar Pawan was first appointed on 05 Jul 2020 as Director at Drsaheb Clinic Private Limited.

The current boards of Mukesh Kumar Pawan's companies include Sarita (Drsaheb Clinic Private Limited), Saumya Bhardwaj (Drsaheb Clinic Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available